Latest news with #StatLab
Business Wire
3 days ago
- Business
- Business Wire
StatLab Empowers Growth in Key European Countries through Direct Market Expansions in Germany and France
MCKINNEY, Texas--(BUSINESS WIRE)--StatLab Medical Products ('StatLab'), a leading global developer and manufacturer of medical diagnostic supplies and equipment, today announced the completed acquisitions of Germany-based histology service and distribution company Histoserve GmbH ('Histoserve') as well as Diapath France SAS ('Diapath France'). These moves mark a significant step forward in StatLab's European growth strategy, expanding its direct commercial presence to the top four European markets: France, Germany, Italy, and the UK, a milestone that positions StatLab among the few suppliers with fully direct access to Europe's largest pathology markets, enabling closer customer relationships and expanded access to StatLab's full product portfolio. This milestone positions StatLab among the few suppliers with direct access to Europe's largest pathology markets, enabling closer customer relationships and expanded access to StatLab's full product portfolio. Share Founded by Wolfgang Jakobi in 2010 near Hannover, Germany, Histoserve has evolved into a comprehensive solutions provider for pathology labs, providing reliable reagents, innovative instrumentation through Diapath, and best-in-class post-sales support. Diapath made a strategic majority investment in Histoserve in 2021 to create a regional hub and direct market access in Germany. With deep equipment service expertise and strong customer ties, Histoserve will play a critical role in expanding market access to the entire StatLab portfolio in Europe's largest market. In parallel, StatLab acquired the remaining stake in Diapath France—a joint venture formed in 2023 between Diapath and Jacques Hannaby to serve the direct laboratory market in France. These additions strengthen StatLab's direct footprint and future scalability in France and Germany while complementing its already established presence in the UK and Italy, and provide the platform to create an industry leader across the four largest European markets and beyond. 'We're thrilled to officially welcome Histoserve and Diapath France into the StatLab family,' said Alberto Battistel, Managing Director of Diapath. 'Although we've collaborated with Wolfgang and Jacques for several years, fully integrating their businesses into our European strategic plan will further strengthen customer relationships and fuel additional growth.' 'The evolution of the StatLab organization has been exciting to witness, and we're proud to now be a full part of their differentiated solution as a result of the completed acquisition,' said Wolfgang Jakobi, founder of Histoserve. 'Our customers will gain access to a broader product portfolio, and together we'll deliver a more unified customer experience, supporting growth with direct labs across Germany and Northern Europe.' About StatLab Medical Products StatLab Medical Products has been dedicated to helping anatomic pathology laboratories provide the best possible patient care since 1976. We offer an extensive portfolio of self-manufactured consumables and equipment from nine manufacturing sites across the United States, United Kingdom, and Europe. Our global operational footprint powered by over 800 mission-driven colleagues delivers a dependable and resilient supply chain of high-quality products and solutions, and a customer-centric approach inspires us to deliver reliability, innovation, and quality in every interaction. About Histoserve Established in Celle, near Hannover, Germany, Histoserve GmbH has delivered decades of histology equipment service—including installation, maintenance, repair, and supply of new and refurbished instruments. With ISO 9001-certified support and a long-standing customer base across Germany and Northern Europe, the company now joins the StatLab family via Diapath to expand its direct-lab service and equipment portfolio.
Yahoo
01-05-2025
- Business
- Yahoo
StatLab Activates New U.S. Manufacturing Capabilities to Secure Supply for Domestic Pathology Labs
Strategic investments reinforce supply chain resilience and streamline U.S. production of essential diagnostic supplies. MCKINNEY, Texas, May 01, 2025--(BUSINESS WIRE)--StatLab Medical Products ("StatLab"), a leading global innovator of pathology supplies, today announced the launch of new U.S.-based manufacturing capabilities, advancing its multi-year "in-region, for-region" strategy to ensure reliable, scalable production of critical reagents for pathology labs nationwide. The latest milestone—insourcing injection-molded prefill containers—further strengthens StatLab's position as one of the top U.S. manufacturers of formalin prefills, producing nearly 100 million units annually, while increasing supply chain reliability for labs amid ongoing global uncertainty. StatLab has a long history of manufacturing StatClick™ formalin prefills, but by becoming the first in its industry to vertically integrate container and lid production in-house, it is increasing control and reducing supply chain risk for this essential product used in operating rooms and labs every day across the U.S. In addition to bringing injection molding for prefill containers in-house, StatLab will also begin blow molding gallon bottles in Q2. Production capacity for cassettes continues to grow as well, with new injection molding cells added at the Arlington facility to meet strong U.S. demand. "At StatLab, it is in our DNA to invest ahead of the need," said Sung-Dae Hong, CEO of StatLab. "As one of the market leaders for essential pathology consumables, insourcing key containers for the products we make, including gallon bottles and prefills, empowers us to control quality and protect our customers against external market forces." In another proactive move to support customers through challenging market conditions, StatLab has announced it will currently absorb any tariff-related fees associated with products manufactured in its European facilities when selling directly to U.S. laboratories. These products include PiSmart cassette and slide printers, KT microscope slides, and KT coverglass. By leveraging its U.S. and European manufacturing capabilities, StatLab is able to offer consumables for the full pathology workflow protected from tariff impact, empowering domestic customers to focus more on patient care. "Delivering stability for our customers, especially in times of volatility, is part of the trust we build every day," continued Hong. "We recognize the importance of predictable pricing and reliable access to the essential supplies labs need for accurate diagnoses." About StatLab Medical Products StatLab Medical Products has been dedicated to helping anatomic pathology laboratories provide the best possible patient care since 1976. Today, with the strength of our united brands and locations around the globe, we're innovating pathology essentials, together. We offer an extensive portfolio of self-manufactured consumables and pathology equipment, developed and produced across nine manufacturing sites in the United States, United Kingdom, and Europe. Our global operational footprint — powered by over 750 mission-driven colleagues — enables an "in-region, for-region" manufacturing strategy, delivering a resilient, dependable supply chain and high-quality solutions. With a customer-centric approach at our core, we bring reliability, innovation, and quality to every interaction. Learn more at View source version on Contacts Jessica Baerjbaer@ 630-346-1659
Associated Press
01-05-2025
- Business
- Associated Press
StatLab Activates New U.S. Manufacturing Capabilities to Secure Supply for Domestic Pathology Labs
MCKINNEY, Texas--(BUSINESS WIRE)--May 1, 2025-- StatLab Medical Products ('StatLab'), a leading global innovator of pathology supplies, today announced the launch of new U.S.-based manufacturing capabilities, advancing its multi-year 'in-region, for-region' strategy to ensure reliable, scalable production of critical reagents for pathology labs nationwide. The latest milestone—insourcing injection-molded prefill containers—further strengthens StatLab's position as one of the top U.S. manufacturers of formalin prefills, producing nearly 100 million units annually, while increasing supply chain reliability for labs amid ongoing global uncertainty. This press release features multimedia. View the full release here: 20 mL StatClick™ prefill containers during injection molding production at the Arlington, Texas StatLab plant. StatLab has a long history of manufacturing StatClick™ formalin prefills, but by becoming the first in its industry to vertically integrate container and lid production in-house, it is increasing control and reducing supply chain risk for this essential product used in operating rooms and labs every day across the U.S. In addition to bringing injection molding for prefill containers in-house, StatLab will also begin blow molding gallon bottles in Q2. Production capacity for cassettes continues to grow as well, with new injection molding cells added at the Arlington facility to meet strong U.S. demand. 'At StatLab, it is in our DNA to invest ahead of the need,' said Sung-Dae Hong, CEO of StatLab. 'As one of the market leaders for essential pathology consumables, insourcing key containers for the products we make, including gallon bottles and prefills, empowers us to control quality and protect our customers against external market forces.' In another proactive move to support customers through challenging market conditions, StatLab has announced it will currently absorb any tariff-related fees associated with products manufactured in its European facilities when selling directly to U.S. laboratories. These products include PiSmart cassette and slide printers, KT microscope slides, and KT coverglass. By leveraging its U.S. and European manufacturing capabilities, StatLab is able to offer consumables for the full pathology workflow protected from tariff impact, empowering domestic customers to focus more on patient care. 'Delivering stability for our customers, especially in times of volatility, is part of the trust we build every day,' continued Hong. 'We recognize the importance of predictable pricing and reliable access to the essential supplies labs need for accurate diagnoses.' About StatLab Medical Products StatLab Medical Products has been dedicated to helping anatomic pathology laboratories provide the best possible patient care since 1976. Today, with the strength of our united brands and locations around the globe, we're innovating pathology essentials, together. We offer an extensive portfolio of self-manufactured consumables and pathology equipment, developed and produced across nine manufacturing sites in the United States, United Kingdom, and Europe. Our global operational footprint — powered by over 750 mission-driven colleagues — enables an 'in-region, for-region' manufacturing strategy, delivering a resilient, dependable supply chain and high-quality solutions. With a customer-centric approach at our core, we bring reliability, innovation, and quality to every interaction. Learn more at View source version on CONTACT: Jessica Baer [email protected] 630-346-1659 KEYWORD: UNITED STATES NORTH AMERICA TEXAS INDUSTRY KEYWORD: MEDICAL DEVICES GENERAL HEALTH HOSPITALS SCIENCE MEDICAL SUPPLIES BIOTECHNOLOGY OTHER MANUFACTURING HEALTH OTHER SCIENCE CHEMICALS/PLASTICS TRANSPORT RESEARCH LOGISTICS/SUPPLY CHAIN MANAGEMENT MANUFACTURING RETAIL OTHER HEALTH SUPPLY CHAIN MANAGEMENT SOURCE: StatLab Medical Products Copyright Business Wire 2025. PUB: 05/01/2025 06:02 AM/DISC: 05/01/2025 06:02 AM
Business Wire
01-05-2025
- Business
- Business Wire
StatLab Activates New U.S. Manufacturing Capabilities to Secure Supply for Domestic Pathology Labs
MCKINNEY, Texas--(BUSINESS WIRE)--StatLab Medical Products ('StatLab'), a leading global innovator of pathology supplies, today announced the launch of new U.S.-based manufacturing capabilities, advancing its multi-year "in-region, for-region" strategy to ensure reliable, scalable production of critical reagents for pathology labs nationwide. The latest milestone—insourcing injection-molded prefill containers—further strengthens StatLab's position as one of the top U.S. manufacturers of formalin prefills, producing nearly 100 million units annually, while increasing supply chain reliability for labs amid ongoing global uncertainty. 'As one of the market leaders for essential pathology consumables, insourcing key containers for the products we make, including gallon bottles and prefills, empowers us to control quality and protect our customers against external market forces.' Share StatLab has a long history of manufacturing StatClick™ formalin prefills, but by becoming the first in its industry to vertically integrate container and lid production in-house, it is increasing control and reducing supply chain risk for this essential product used in operating rooms and labs every day across the U.S. In addition to bringing injection molding for prefill containers in-house, StatLab will also begin blow molding gallon bottles in Q2. Production capacity for cassettes continues to grow as well, with new injection molding cells added at the Arlington facility to meet strong U.S. demand. 'At StatLab, it is in our DNA to invest ahead of the need,' said Sung-Dae Hong, CEO of StatLab. 'As one of the market leaders for essential pathology consumables, insourcing key containers for the products we make, including gallon bottles and prefills, empowers us to control quality and protect our customers against external market forces.' In another proactive move to support customers through challenging market conditions, StatLab has announced it will currently absorb any tariff-related fees associated with products manufactured in its European facilities when selling directly to U.S. laboratories. These products include PiSmart cassette and slide printers, KT microscope slides, and KT coverglass. By leveraging its U.S. and European manufacturing capabilities, StatLab is able to offer consumables for the full pathology workflow protected from tariff impact, empowering domestic customers to focus more on patient care. 'Delivering stability for our customers, especially in times of volatility, is part of the trust we build every day,' continued Hong. 'We recognize the importance of predictable pricing and reliable access to the essential supplies labs need for accurate diagnoses.' About StatLab Medical Products StatLab Medical Products has been dedicated to helping anatomic pathology laboratories provide the best possible patient care since 1976. Today, with the strength of our united brands and locations around the globe, we're innovating pathology essentials, together. We offer an extensive portfolio of self-manufactured consumables and pathology equipment, developed and produced across nine manufacturing sites in the United States, United Kingdom, and Europe. Our global operational footprint — powered by over 750 mission-driven colleagues — enables an 'in-region, for-region' manufacturing strategy, delivering a resilient, dependable supply chain and high-quality solutions. With a customer-centric approach at our core, we bring reliability, innovation, and quality to every interaction. Learn more at
